(Q44428979)

2 December 2017

DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study (English)

1 reference

2 December 2017

0 references

0 references

1 reference

1 reference

10

Abraham Weizman

1 reference

2 December 2017

1

Gil Zalsman

1 reference

2 December 2017

Amos Frisch

2

1 reference

2 December 2017

Shaul Lev-Ran

3

1 reference

2 December 2017

Andrés Martin

4

1 reference

2 December 2017

Elena Michaelovsky

5

1 reference

2 December 2017

Daniela Bensason

6

1 reference

2 December 2017

Doron Gothelf

7

1 reference

2 December 2017

Eitan Nahshoni

8

1 reference

2 December 2017

Samuel Tyano

9

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

European Neuropsychopharmacology

2 December 2017

1 reference

2 December 2017

13

1 reference

2 December 2017

183-185

1 reference

2 December 2017

3

1 reference

Psychometric properties of the K-SADS-P in an Israeli adolescent inpatient population.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Pharmacogenetics of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of Novelty Seeking.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Association study between the dopamine D4 receptor gene and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

1 reference

7 January 2021

Child and adolescent schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Genetic Variants of Dopamine Receptor D4 and Psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Association of the dopamine transporter gene (DAT1) with poor methylphenidate response

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

Multiple dopamine D4 receptor variants in the human population

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900006-3

7 January 2021

10.1016/S0924-977X(03)00006-3

Identifiers

DOI

1 reference

2 December 2017

1 reference